181 related articles for article (PubMed ID: 29542252)
1. Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma.
Guo W; Ma J; Pei T; Zhao T; Guo S; Yi X; Liu Y; Wang S; Zhu G; Jian Z; Gao T; Li C; Liao W; Shi Q
J Cell Mol Med; 2018 May; 22(5):2944-2954. PubMed ID: 29542252
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition.
Qiu C; Liu Y; Mei Y; Zou M; Zhao Z; Ye M; Wu X
Aging (Albany NY); 2018 Oct; 10(10):2783-2799. PubMed ID: 30335615
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination.
Li T; Yan B; Ma Y; Weng J; Yang S; Zhao N; Wang X; Sun X
Cell Death Dis; 2018 Feb; 9(2):148. PubMed ID: 29396555
[TBL] [Abstract][Full Text] [Related]
4. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.
Zhang H; Han Y; Xiao W; Gao Y; Sui Z; Ren P; Meng F; Tang P; Yu Z
Cell Death Dis; 2023 Nov; 14(11):730. PubMed ID: 37949874
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
Xing C; Lu XX; Guo PD; Shen T; Zhang S; He XS; Gan WJ; Li XM; Wang JR; Zhao YY; Wu H; Li JM
Cancer Res; 2016 Jan; 76(1):83-95. PubMed ID: 26669864
[TBL] [Abstract][Full Text] [Related]
7. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1.
Zhang X; Berger FG; Yang J; Lu X
EMBO J; 2011 Jun; 30(11):2177-89. PubMed ID: 21522127
[TBL] [Abstract][Full Text] [Related]
8. MIR99AHG inhibits EMT in pulmonary fibrosis via the miR-136-5p/USP4/ACE2 axis.
Wang J; Xiang Y; Yang SX; Zhang HM; Li H; Zong QB; Li LW; Zhao LL; Xia RH; Li C; Bao LY; Zhang TC; Liao XH
J Transl Med; 2022 Sep; 20(1):426. PubMed ID: 36138468
[TBL] [Abstract][Full Text] [Related]
9. USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2.
Li Z; Hao Q; Luo J; Xiong J; Zhang S; Wang T; Bai L; Wang W; Chen M; Wang W; Gu L; Lv K; Chen J
Oncogene; 2016 Jun; 35(22):2902-12. PubMed ID: 26411366
[TBL] [Abstract][Full Text] [Related]
10. LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition.
Li R; Shang R; Li S; Ren Y; Shen L; Yang L; Chen S; Chen X; Li J; Xu M
Environ Toxicol; 2022 Oct; 37(10):2540-2551. PubMed ID: 35841383
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer.
Wang Y; Zhou L; Lu J; Jiang B; Liu C; Liang Z; Zhou W; Guo J
Exp Cell Res; 2020 Nov; 396(2):112317. PubMed ID: 33038351
[TBL] [Abstract][Full Text] [Related]
12. FBXO3 stabilizes USP4 and Twist1 to promote PI3K-mediated breast cancer metastasis.
Xu J; Guo R; Wen N; Li L; Yi Y; Chen J; He Z; Yang J; Xiao ZJ; Niu M
PLoS Biol; 2023 Dec; 21(12):e3002446. PubMed ID: 38134227
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4.
Li Y; Jiang D; Zhang Q; Liu X; Cai Z
Int J Mol Med; 2016 Sep; 38(3):803-11. PubMed ID: 27430936
[TBL] [Abstract][Full Text] [Related]
15. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer.
Zhou Y; Li H; Zhang Y; Zhao E; Huang C; Pan X; Shu F; Liu Z; Tang N; Li F; Liao W
Cancer Lett; 2024 May; 589():216836. PubMed ID: 38556105
[TBL] [Abstract][Full Text] [Related]
17. OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5.
Kang XY; Zhang J; Tang L; Huang L; Tong J; Fu Q
Chem Biol Drug Des; 2020 Aug; 96(2):790-800. PubMed ID: 32248621
[TBL] [Abstract][Full Text] [Related]
18. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
[TBL] [Abstract][Full Text] [Related]
19. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-specific protease 4 (USP4) suppresses myoblast differentiation by down regulating MyoD activity in a catalytic-independent manner.
Yun SI; Kim KK
Cell Signal; 2017 Jul; 35():48-60. PubMed ID: 28336234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
